NASDAQ:ACHV

Achieve Life Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy ACHV

*Your capital is at risk

$4.92

-0.110 (-2.19%)

At Close: Jun 03, 2026

Achieve Life Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 82.80. In total, the insiders bought 31.94M and sold 763.94K ACHV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	82.80
● Buy	31.94M shares
● Sell	763.94K shares
88% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Apr 17, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 82.8. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (88% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 29, 2026 Buy	No securities are beneficially owned	Farrow Jeffrey S Director	Director	0 Value: $0
May 29, 2026 Buy	No securities are beneficially owned	Waldman Reid Alexander Director	Director	0 Value: $0
May 29, 2026 Buy	Stock Option (right to buy) A-Award	Farrow Jeffrey S Director	Director	47 250 Value: $247.6K
May 29, 2026 Buy	Stock Option (right to buy) A-Award	Waldman Reid Alexander Director	Director	47 250 Value: $247.6K
May 11, 2026 Buy	No securities are beneficially owned	Martin Christopher Nathan Director	Director	0 Value: $0
May 11, 2026 Buy	Stock Option (right to buy) A-Award	Martin Christopher Nathan Director	Director	47 250 Value: $264.1K
Apr 18, 2026 Buy	Performance Restricted Stock Unit (PRSU) A-Award	Goldberg Andrew D. CEO And President	CEO / President	11 706 270 Value: $57.6M
Apr 18, 2026 Buy	Stock Option (right to buy) A-Award	Goldberg Andrew D. CEO And President	CEO / President	3 601 929 Value: $15.3M
Apr 18, 2026 Buy	Restricted Stock Unit (RSU) A-Award	Goldberg Andrew D. CEO And President	CEO / President	1 800 965 Value: $8.86M
Apr 18, 2026 Buy	No securities are beneficially owned	Goldberg Andrew D. CEO And President	CEO / President	0 Value: $0
Apr 17, 2026 Buy	No securities are beneficially owned	Royston Aaron Director	Director	0 Value: $0
Apr 17, 2026 Buy	No securities beneficially owned	Iancovici Lucian Director	Director	0 Value: $0
Apr 17, 2026 Buy	Warrants (right to buy)	Tpg Gp A, Llc 10 Percent Owner	10% Owner	6 877 580 Value: $24.1M
Apr 17, 2026 Buy	Common Stock	Tpg Gp A, Llc 10 Percent Owner	10% Owner	0 Value: $0
Jan 28, 2026 Buy	Stock Option (right to buy) A-Award	Oki Mark K Chief Financial Officer	C-Suite Officer	180 000 Value: $784.8K
Jan 28, 2026 Buy	Stock Option (right to buy) A-Award	Rubinstein Mark Lawrence Chief Medical Officer	Officer	180 000 Value: $784.8K
Jan 28, 2026 Buy	Stock Option (right to buy) A-Award	Xinos Jaime Chief Commercial Officer	Officer	180 000 Value: $784.8K
Jan 28, 2026 Buy	Stock Option (right to buy) A-Award	Donnelly Craig Chief Operations Officer	Officer	180 000 Value: $784.8K
Jan 28, 2026 Buy	Stock Option (right to buy) A-Award	Stewart Richard Alistair Chief Executive Officer	CEO / President	645 000 Value: $2.81M
Jan 28, 2026 Buy	Stock Option (right to buy) A-Award	Wan Jerry Principal Accounting Officer	Officer	70 300 Value: $306.5K
Jan 01, 2026 Buy	Stock Option (right to buy)	Rubinstein Mark Lawrence Chief Medical Officer	Officer	50 000 Value: $155.0K
Jan 01, 2026 Buy	Stock Option (right to buy)	Rubinstein Mark Lawrence Chief Medical Officer	Officer	47 000 Value: $212.4K
Jan 01, 2026 Buy	Common Stock	Rubinstein Mark Lawrence Chief Medical Officer	Officer	0 Value: $0
Dec 04, 2025 Buy	Stock Option (right to buy) A-Award	Atkisson Erik Chief Legal Officer	Officer	250 000 Value: $1.20M
Oct 20, 2025 Buy	No securities are beneficially owned	Atkisson Erik Chief Legal Officer	Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ACHIEVE LIFE SCIENCES, INC.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol....

Read Full Profile Here